SKF107457, an innovative biomedicine, presents an efficacious treatment modality for an array of ailments. Functioning as an influential and specific stimulator of the glucagon-like peptide-1 receptor (GLP-1R), this product proffers a promising avenue for managing afflictions like type 2 diabetes, obesity, and neurodegenerative disorders. Its intricate mode of operation encompasses augmenting insulin release contingent upon glucose levels and fostering satiety, ultimately culminating in enhanced glycemic regulation and profound reductions in body weight.
CAT No: R2077
CAS No:126333-28-6
Chemical Name:methyl (2S)-2-[[(2S)-2-[[(4S,5S)-5-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-4-hydroxy-6-phenylhexanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoate
SKF107457 is a synthetic small molecule that functions as a selective inhibitor of protein kinase C (PKC) isoforms, particularly targeting the conventional and novel subclasses. As a non-peptidic compound, it is structurally designed to modulate intracellular signaling pathways mediated by PKC, a family of serine/threonine kinases that play critical roles in regulating cell proliferation, differentiation, and apoptosis. SKF107457 is widely recognized in biochemical research for its utility in dissecting the complex regulatory mechanisms of PKC-dependent processes, making it a valuable tool for elucidating cellular signal transduction networks and their implications in physiological as well as pathological contexts.
Signal transduction research: As a selective PKC inhibitor, SKF107457 is extensively employed in studies aimed at unraveling the intricacies of signal transduction cascades. By selectively blocking PKC activity, researchers can delineate the specific contributions of PKC-mediated phosphorylation events within broader signaling pathways. This capability is essential for mapping the downstream effects of PKC activation and for distinguishing its role from other kinase families, thereby providing a clearer understanding of cellular responses to external stimuli.
Cellular function analysis: The compound is instrumental in probing the influence of PKC on fundamental cellular processes such as proliferation, migration, and programmed cell death. By inhibiting PKC, SKF107457 enables scientists to investigate the kinase's involvement in the regulation of cell cycle checkpoints, cytoskeletal reorganization, and apoptotic signaling. Such studies are critical for identifying molecular determinants of cell fate and for exploring how dysregulation of PKC activity may contribute to aberrant cellular behaviors.
Pharmacological profiling: SKF107457 serves as an important reference compound in the pharmacological characterization of novel PKC modulators. Its well-defined inhibitory profile allows for comparative studies in which the specificity and potency of new small molecules are benchmarked against established inhibitors. This application is particularly valuable in early-stage drug discovery, where precise assessment of target engagement and off-target effects is necessary for lead optimization.
Neuroscience research: The role of PKC in neuronal signaling and plasticity has made SKF107457 a key tool in neurobiological investigations. Researchers utilize the compound to examine how PKC-dependent mechanisms influence neurotransmitter release, synaptic remodeling, and neuronal excitability. Such studies contribute to the broader understanding of neural circuit dynamics and may inform the development of strategies for modulating synaptic function in experimental models.
Cancer biology studies: Due to the involvement of PKC isoforms in tumorigenic processes, SKF107457 is frequently applied in cancer research to explore the kinase's impact on oncogenic signaling networks. By selectively inhibiting PKC activity, researchers can assess its role in cancer cell proliferation, survival, and metastasis. These investigations provide critical insights into the molecular underpinnings of cancer progression and support the identification of potential targets for future therapeutic intervention.
Through its selective inhibition of PKC isoforms, SKF107457 offers researchers a robust and reliable means of interrogating diverse aspects of cellular signaling, functional regulation, and pathway-specific modulation. Its applications span fundamental mechanistic studies and translational research contexts, underscoring its value as a versatile tool for advancing biochemical and cell biological knowledge.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More